– Proteomics International Laboratories (ASXIQ) was flat at 50c after the medtech company announced the publication of two studies validating its predictive test for diabetic kidney disease. The results form a basis for regulatory approvals related to its PromarkerD test and its adoption by pathology laboratories worldwide, Proteomics said.
Ann: PromarkerD clinical assay performance results published, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.020(2.30%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 88.0¢ | 84.5¢ | $104.5K | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12500 | 85.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 2526 | 1 |
View Market Depth
| Last trade - 15.32pm 15/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |